Share Price and Basic Stock Data
Last Updated: November 14, 2025, 9:20 am
| PEG Ratio | -1.29 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
IVP Ltd operates in the organic chemicals sector and has shown a fluctuating revenue trajectory over recent years. For the fiscal year ending March 2023, the company reported sales of ₹661 Cr, which was a significant increase from ₹557 Cr in the previous year. However, projections for the following year show a decline to ₹546 Cr for FY 2024, and further down to ₹539 Cr for FY 2025. Quarterly sales figures reflect this volatility, with the highest quarterly revenue of ₹175.45 Cr recorded in March 2023, followed by a decline to ₹139.58 Cr in June 2023. The company’s ability to maintain sales momentum will be crucial, especially as it navigates a competitive landscape where fluctuations in demand and pricing can impact overall performance.
Profitability and Efficiency Metrics
IVP Ltd’s profitability metrics reveal a mixed performance. The company’s operating profit margin (OPM) stood at 3.08% for the latest reporting period, indicating a modest ability to convert sales into profit compared to industry standards. The net profit for FY 2023 reached ₹28 Cr, translating to an earnings per share (EPS) of ₹27.13, which reflects a decline from ₹17.07 in FY 2022. The interest coverage ratio (ICR) is strong at 3.69x, suggesting that the company can comfortably meet its interest obligations. However, the return on equity (ROE) at 8.44% and return on capital employed (ROCE) at 9.99% are relatively low, indicating that while the company is generating profits, it may not be utilizing its capital as efficiently as some of its peers in the sector, which typically exhibit higher returns.
Balance Sheet Strength and Financial Ratios
IVP Ltd’s balance sheet reflects a cautious approach towards debt management, with total borrowings reported at ₹104 Cr against reserves of ₹129 Cr. This gives a debt-to-equity ratio of 0.74, indicating a reasonable leverage level compared to industry norms. The company’s total assets stood at ₹350 Cr, with a book value per share of ₹134.88, which is a solid indicator of underlying value. The current ratio of 1.32x suggests adequate liquidity to cover short-term obligations. However, the cash conversion cycle at 116 days points to potential inefficiencies in managing working capital. The company needs to improve its inventory and receivables management to enhance liquidity and operational efficiency. Overall, while the balance sheet appears stable, the efficiency ratios highlight areas for improvement.
Shareholding Pattern and Investor Confidence
Investor confidence in IVP Ltd is predominantly reflected in its shareholding structure. Promoters hold a substantial 71.32% of the equity, indicating strong control and commitment to the company’s direction. However, institutional investment remains negligible, with foreign institutional investors (FIIs) at 0.00% and domestic institutional investors (DIIs) at just 0.02%. The public shareholding has slightly increased to 28.67%, suggesting a growing interest among retail investors. The number of shareholders has also risen to 7,199, up from 5,361 in September 2022, indicating a positive trend in retail participation. This concentrated promoter holding may instill confidence, but the lack of institutional backing could pose risks regarding stock liquidity and market perception.
Outlook, Risks, and Final Insight
Looking ahead, IVP Ltd faces both opportunities and challenges. The company’s focus on maintaining revenue stability and improving profitability will be critical in a volatile chemical market. Risks include the potential for declining sales as indicated by recent quarterly results and the low profitability margins compared to industry standards. Additionally, external factors such as raw material price fluctuations and regulatory changes could impact operational efficiency. Strengths lie in its solid balance sheet and strong promoter backing, which can provide a cushion during tough market conditions. To enhance shareholder value, IVP Ltd must concentrate on improving its operational efficiency, increasing profitability margins, and potentially expanding its market presence. The company’s strategies in addressing these areas will be vital for its future performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of IVP Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 107 Cr. | 301 | 456/255 | 111 | 390 | 0.03 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,766 Cr. | 9,796 | 14,250/8,150 | 56.2 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 36.6 Cr. | 122 | 329/114 | 18.1 | 26.9 | 0.82 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 35.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 297 Cr. | 371 | 387/163 | 16.5 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,345.86 Cr | 1,641.88 | 389.55 | 332.47 | 0.38% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 162.17 | 167.19 | 156.14 | 175.45 | 139.58 | 141.97 | 122.33 | 142.23 | 138.26 | 122.01 | 129.36 | 149.36 | 138.19 |
| Expenses | 154.01 | 160.17 | 146.50 | 160.62 | 134.69 | 132.95 | 117.24 | 133.40 | 131.44 | 116.48 | 124.28 | 141.59 | 133.94 |
| Operating Profit | 8.16 | 7.02 | 9.64 | 14.83 | 4.89 | 9.02 | 5.09 | 8.83 | 6.82 | 5.53 | 5.08 | 7.77 | 4.25 |
| OPM % | 5.03% | 4.20% | 6.17% | 8.45% | 3.50% | 6.35% | 4.16% | 6.21% | 4.93% | 4.53% | 3.93% | 5.20% | 3.08% |
| Other Income | 0.64 | 5.09 | 9.19 | 0.82 | 0.76 | 0.75 | 0.69 | 0.83 | 0.81 | 0.79 | 1.04 | 0.94 | 1.06 |
| Interest | 2.80 | 3.38 | 3.12 | 2.94 | 2.61 | 2.23 | 2.00 | 1.85 | 1.82 | 1.82 | 2.05 | 2.10 | 2.11 |
| Depreciation | 1.28 | 1.32 | 1.31 | 1.29 | 1.36 | 1.38 | 1.40 | 1.40 | 1.39 | 1.41 | 1.47 | 1.46 | 1.50 |
| Profit before tax | 4.72 | 7.41 | 14.40 | 11.42 | 1.68 | 6.16 | 2.38 | 6.41 | 4.42 | 3.09 | 2.60 | 5.15 | 1.70 |
| Tax % | 25.85% | 22.94% | 28.68% | 25.22% | 29.17% | 24.68% | 28.15% | 26.05% | 22.40% | 30.10% | 27.31% | 25.63% | 30.00% |
| Net Profit | 3.50 | 5.71 | 10.27 | 8.54 | 1.19 | 4.64 | 1.71 | 4.74 | 3.43 | 2.16 | 1.89 | 3.83 | 1.19 |
| EPS in Rs | 3.39 | 5.53 | 9.95 | 8.27 | 1.15 | 4.49 | 1.66 | 4.59 | 3.32 | 2.09 | 1.83 | 3.71 | 1.15 |
Last Updated: August 1, 2025, 7:05 pm
Below is a detailed analysis of the quarterly data for IVP Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 138.19 Cr.. The value appears to be declining and may need further review. It has decreased from 149.36 Cr. (Mar 2025) to 138.19 Cr., marking a decrease of 11.17 Cr..
- For Expenses, as of Jun 2025, the value is 133.94 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 141.59 Cr. (Mar 2025) to 133.94 Cr., marking a decrease of 7.65 Cr..
- For Operating Profit, as of Jun 2025, the value is 4.25 Cr.. The value appears to be declining and may need further review. It has decreased from 7.77 Cr. (Mar 2025) to 4.25 Cr., marking a decrease of 3.52 Cr..
- For OPM %, as of Jun 2025, the value is 3.08%. The value appears to be declining and may need further review. It has decreased from 5.20% (Mar 2025) to 3.08%, marking a decrease of 2.12%.
- For Other Income, as of Jun 2025, the value is 1.06 Cr.. The value appears strong and on an upward trend. It has increased from 0.94 Cr. (Mar 2025) to 1.06 Cr., marking an increase of 0.12 Cr..
- For Interest, as of Jun 2025, the value is 2.11 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.10 Cr. (Mar 2025) to 2.11 Cr., marking an increase of 0.01 Cr..
- For Depreciation, as of Jun 2025, the value is 1.50 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.46 Cr. (Mar 2025) to 1.50 Cr., marking an increase of 0.04 Cr..
- For Profit before tax, as of Jun 2025, the value is 1.70 Cr.. The value appears to be declining and may need further review. It has decreased from 5.15 Cr. (Mar 2025) to 1.70 Cr., marking a decrease of 3.45 Cr..
- For Tax %, as of Jun 2025, the value is 30.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.63% (Mar 2025) to 30.00%, marking an increase of 4.37%.
- For Net Profit, as of Jun 2025, the value is 1.19 Cr.. The value appears to be declining and may need further review. It has decreased from 3.83 Cr. (Mar 2025) to 1.19 Cr., marking a decrease of 2.64 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.15. The value appears to be declining and may need further review. It has decreased from 3.71 (Mar 2025) to 1.15, marking a decrease of 2.56.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:05 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 146 | 163 | 155 | 161 | 270 | 320 | 229 | 290 | 557 | 661 | 546 | 539 | 539 |
| Expenses | 142 | 153 | 140 | 144 | 249 | 310 | 229 | 273 | 521 | 621 | 518 | 514 | 516 |
| Operating Profit | 4 | 11 | 15 | 17 | 21 | 9 | -0 | 16 | 35 | 40 | 28 | 25 | 23 |
| OPM % | 3% | 7% | 9% | 11% | 8% | 3% | -0% | 6% | 6% | 6% | 5% | 5% | 4% |
| Other Income | 2 | 1 | 5 | 1 | 1 | 2 | 2 | 2 | 3 | 16 | 3 | 4 | 4 |
| Interest | 0 | 1 | 0 | 0 | 3 | 8 | 10 | 7 | 10 | 12 | 9 | 8 | 8 |
| Depreciation | 1 | 1 | 1 | 1 | 3 | 3 | 5 | 5 | 5 | 5 | 6 | 6 | 6 |
| Profit before tax | 4 | 10 | 18 | 17 | 16 | 0 | -13 | 7 | 23 | 38 | 17 | 15 | 13 |
| Tax % | 41% | 34% | 42% | 36% | 37% | -1,107% | -33% | 33% | 24% | 26% | 26% | 26% | |
| Net Profit | 2 | 7 | 10 | 11 | 10 | 3 | -9 | 4 | 18 | 28 | 12 | 11 | 9 |
| EPS in Rs | 2.38 | 6.71 | 10.09 | 10.47 | 10.06 | 3.27 | -8.35 | 4.36 | 17.07 | 27.13 | 11.89 | 10.95 | 8.78 |
| Dividend Payout % | 42% | 30% | 20% | 19% | 20% | 31% | 0% | 23% | 9% | 6% | 8% | 9% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 250.00% | 42.86% | 10.00% | -9.09% | -70.00% | -400.00% | 144.44% | 350.00% | 55.56% | -57.14% | -8.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | -207.14% | -32.86% | -19.09% | -60.91% | -330.00% | 544.44% | 205.56% | -294.44% | -112.70% | 48.81% |
IVP Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 19% |
| 3 Years: | -1% |
| TTM: | -1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 27% |
| 3 Years: | -14% |
| TTM: | -38% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 30% |
| 3 Years: | 2% |
| 1 Year: | -20% |
| Return on Equity | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 12% |
| 3 Years: | 12% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 7:55 am
Balance Sheet
Last Updated: November 9, 2025, 2:17 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 42 | 45 | 52 | 63 | 71 | 71 | 61 | 65 | 81 | 108 | 119 | 129 | 134 |
| Borrowings | 4 | 4 | 0 | 14 | 78 | 143 | 99 | 122 | 157 | 120 | 89 | 104 | 100 |
| Other Liabilities | 35 | 34 | 42 | 47 | 88 | 50 | 49 | 106 | 122 | 147 | 114 | 106 | 87 |
| Total Liabilities | 91 | 93 | 105 | 134 | 247 | 275 | 220 | 304 | 371 | 385 | 333 | 350 | 331 |
| Fixed Assets | 15 | 15 | 16 | 35 | 41 | 59 | 84 | 79 | 77 | 73 | 71 | 72 | 69 |
| CWIP | 0 | 0 | 1 | 2 | 17 | 26 | 0 | 0 | 0 | 2 | 2 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 75 | 78 | 88 | 96 | 188 | 189 | 136 | 224 | 293 | 310 | 260 | 278 | 261 |
| Total Assets | 91 | 93 | 105 | 134 | 247 | 275 | 220 | 304 | 371 | 385 | 333 | 350 | 331 |
Below is a detailed analysis of the balance sheet data for IVP Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
- For Reserves, as of Sep 2025, the value is 134.00 Cr.. The value appears strong and on an upward trend. It has increased from 129.00 Cr. (Mar 2025) to 134.00 Cr., marking an increase of 5.00 Cr..
- For Borrowings, as of Sep 2025, the value is 100.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 104.00 Cr. (Mar 2025) to 100.00 Cr., marking a decrease of 4.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 87.00 Cr.. The value appears to be improving (decreasing). It has decreased from 106.00 Cr. (Mar 2025) to 87.00 Cr., marking a decrease of 19.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 331.00 Cr.. The value appears to be improving (decreasing). It has decreased from 350.00 Cr. (Mar 2025) to 331.00 Cr., marking a decrease of 19.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 69.00 Cr.. The value appears to be declining and may need further review. It has decreased from 72.00 Cr. (Mar 2025) to 69.00 Cr., marking a decrease of 3.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 261.00 Cr.. The value appears to be declining and may need further review. It has decreased from 278.00 Cr. (Mar 2025) to 261.00 Cr., marking a decrease of 17.00 Cr..
- For Total Assets, as of Sep 2025, the value is 331.00 Cr.. The value appears to be declining and may need further review. It has decreased from 350.00 Cr. (Mar 2025) to 331.00 Cr., marking a decrease of 19.00 Cr..
Notably, the Reserves (134.00 Cr.) exceed the Borrowings (100.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.00 | 7.00 | 15.00 | 3.00 | -57.00 | -134.00 | -99.00 | -106.00 | -122.00 | -80.00 | -61.00 | -79.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 134 | 135 | 131 | 135 | 144 | 140 | 147 | 175 | 137 | 115 | 115 | 123 |
| Inventory Days | 43 | 32 | 63 | 80 | 103 | 68 | 62 | 118 | 63 | 62 | 64 | 72 |
| Days Payable | 53 | 44 | 69 | 78 | 109 | 61 | 91 | 162 | 89 | 89 | 86 | 79 |
| Cash Conversion Cycle | 124 | 123 | 126 | 137 | 138 | 147 | 118 | 131 | 110 | 88 | 92 | 116 |
| Working Capital Days | 88 | 84 | 87 | 72 | 17 | -14 | -34 | -15 | 9 | 26 | 38 | 46 |
| ROCE % | 7% | 19% | 24% | 23% | 16% | 5% | -1% | 7% | 15% | 15% | 11% | 10% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 10.96 | 11.89 | 27.13 | 17.07 | 4.35 |
| Diluted EPS (Rs.) | 10.96 | 11.89 | 27.13 | 17.07 | 4.35 |
| Cash EPS (Rs.) | 16.50 | 17.25 | 32.16 | 22.02 | 9.25 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 134.88 | 125.48 | 114.89 | 88.78 | 73.28 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 134.88 | 125.48 | 114.89 | 88.78 | 73.28 |
| Dividend / Share (Rs.) | 1.00 | 1.00 | 1.50 | 1.50 | 1.00 |
| Revenue From Operations / Share (Rs.) | 521.77 | 528.65 | 639.84 | 538.80 | 280.43 |
| PBDIT / Share (Rs.) | 27.86 | 29.88 | 41.13 | 37.18 | 18.11 |
| PBIT / Share (Rs.) | 22.31 | 24.52 | 36.10 | 32.23 | 13.21 |
| PBT / Share (Rs.) | 14.77 | 16.10 | 36.74 | 22.60 | 6.47 |
| Net Profit / Share (Rs.) | 10.95 | 11.89 | 27.12 | 17.07 | 4.36 |
| PBDIT Margin (%) | 5.33 | 5.65 | 6.42 | 6.90 | 6.45 |
| PBIT Margin (%) | 4.27 | 4.63 | 5.64 | 5.98 | 4.71 |
| PBT Margin (%) | 2.83 | 3.04 | 5.74 | 4.19 | 2.30 |
| Net Profit Margin (%) | 2.09 | 2.24 | 4.23 | 3.16 | 1.55 |
| Return on Networth / Equity (%) | 8.11 | 9.47 | 23.60 | 19.22 | 5.94 |
| Return on Capital Employeed (%) | 16.32 | 19.06 | 30.31 | 35.35 | 17.87 |
| Return On Assets (%) | 3.25 | 3.71 | 7.30 | 4.75 | 1.47 |
| Total Debt / Equity (X) | 0.74 | 0.68 | 1.01 | 1.71 | 1.62 |
| Asset Turnover Ratio (%) | 1.59 | 1.53 | 1.75 | 1.65 | 1.10 |
| Current Ratio (X) | 1.32 | 1.29 | 1.18 | 1.05 | 0.95 |
| Quick Ratio (X) | 0.91 | 0.90 | 0.82 | 0.76 | 0.63 |
| Inventory Turnover Ratio (X) | 6.76 | 5.22 | 6.41 | 6.09 | 4.57 |
| Dividend Payout Ratio (NP) (%) | 9.10 | 12.62 | 5.53 | 5.84 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 6.04 | 8.69 | 4.66 | 4.52 | 0.00 |
| Earning Retention Ratio (%) | 90.90 | 87.38 | 94.47 | 94.16 | 0.00 |
| Cash Earning Retention Ratio (%) | 93.96 | 91.31 | 95.34 | 95.48 | 0.00 |
| Interest Coverage Ratio (X) | 3.69 | 3.55 | 3.47 | 3.86 | 2.68 |
| Interest Coverage Ratio (Post Tax) (X) | 2.45 | 2.41 | 2.24 | 2.77 | 1.65 |
| Enterprise Value (Cr.) | 252.41 | 244.62 | 243.20 | 308.69 | 220.98 |
| EV / Net Operating Revenue (X) | 0.46 | 0.44 | 0.36 | 0.55 | 0.76 |
| EV / EBITDA (X) | 8.77 | 7.92 | 5.72 | 8.04 | 11.81 |
| MarketCap / Net Operating Revenue (X) | 0.27 | 0.28 | 0.18 | 0.27 | 0.34 |
| Retention Ratios (%) | 90.89 | 87.37 | 94.46 | 94.15 | 0.00 |
| Price / BV (X) | 1.07 | 1.21 | 1.05 | 1.67 | 1.33 |
| Price / Net Operating Revenue (X) | 0.27 | 0.28 | 0.18 | 0.27 | 0.34 |
| EarningsYield | 0.07 | 0.07 | 0.22 | 0.11 | 0.04 |
After reviewing the key financial ratios for IVP Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 10.96. This value is within the healthy range. It has decreased from 11.89 (Mar 24) to 10.96, marking a decrease of 0.93.
- For Diluted EPS (Rs.), as of Mar 25, the value is 10.96. This value is within the healthy range. It has decreased from 11.89 (Mar 24) to 10.96, marking a decrease of 0.93.
- For Cash EPS (Rs.), as of Mar 25, the value is 16.50. This value is within the healthy range. It has decreased from 17.25 (Mar 24) to 16.50, marking a decrease of 0.75.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 134.88. It has increased from 125.48 (Mar 24) to 134.88, marking an increase of 9.40.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 134.88. It has increased from 125.48 (Mar 24) to 134.88, marking an increase of 9.40.
- For Dividend / Share (Rs.), as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 521.77. It has decreased from 528.65 (Mar 24) to 521.77, marking a decrease of 6.88.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 27.86. This value is within the healthy range. It has decreased from 29.88 (Mar 24) to 27.86, marking a decrease of 2.02.
- For PBIT / Share (Rs.), as of Mar 25, the value is 22.31. This value is within the healthy range. It has decreased from 24.52 (Mar 24) to 22.31, marking a decrease of 2.21.
- For PBT / Share (Rs.), as of Mar 25, the value is 14.77. This value is within the healthy range. It has decreased from 16.10 (Mar 24) to 14.77, marking a decrease of 1.33.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 10.95. This value is within the healthy range. It has decreased from 11.89 (Mar 24) to 10.95, marking a decrease of 0.94.
- For PBDIT Margin (%), as of Mar 25, the value is 5.33. This value is below the healthy minimum of 10. It has decreased from 5.65 (Mar 24) to 5.33, marking a decrease of 0.32.
- For PBIT Margin (%), as of Mar 25, the value is 4.27. This value is below the healthy minimum of 10. It has decreased from 4.63 (Mar 24) to 4.27, marking a decrease of 0.36.
- For PBT Margin (%), as of Mar 25, the value is 2.83. This value is below the healthy minimum of 10. It has decreased from 3.04 (Mar 24) to 2.83, marking a decrease of 0.21.
- For Net Profit Margin (%), as of Mar 25, the value is 2.09. This value is below the healthy minimum of 5. It has decreased from 2.24 (Mar 24) to 2.09, marking a decrease of 0.15.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.11. This value is below the healthy minimum of 15. It has decreased from 9.47 (Mar 24) to 8.11, marking a decrease of 1.36.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.32. This value is within the healthy range. It has decreased from 19.06 (Mar 24) to 16.32, marking a decrease of 2.74.
- For Return On Assets (%), as of Mar 25, the value is 3.25. This value is below the healthy minimum of 5. It has decreased from 3.71 (Mar 24) to 3.25, marking a decrease of 0.46.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.74. This value is within the healthy range. It has increased from 0.68 (Mar 24) to 0.74, marking an increase of 0.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.59. It has increased from 1.53 (Mar 24) to 1.59, marking an increase of 0.06.
- For Current Ratio (X), as of Mar 25, the value is 1.32. This value is below the healthy minimum of 1.5. It has increased from 1.29 (Mar 24) to 1.32, marking an increase of 0.03.
- For Quick Ratio (X), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 1. It has increased from 0.90 (Mar 24) to 0.91, marking an increase of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.76. This value is within the healthy range. It has increased from 5.22 (Mar 24) to 6.76, marking an increase of 1.54.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 9.10. This value is below the healthy minimum of 20. It has decreased from 12.62 (Mar 24) to 9.10, marking a decrease of 3.52.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 6.04. This value is below the healthy minimum of 20. It has decreased from 8.69 (Mar 24) to 6.04, marking a decrease of 2.65.
- For Earning Retention Ratio (%), as of Mar 25, the value is 90.90. This value exceeds the healthy maximum of 70. It has increased from 87.38 (Mar 24) to 90.90, marking an increase of 3.52.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 93.96. This value exceeds the healthy maximum of 70. It has increased from 91.31 (Mar 24) to 93.96, marking an increase of 2.65.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.69. This value is within the healthy range. It has increased from 3.55 (Mar 24) to 3.69, marking an increase of 0.14.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.45. This value is below the healthy minimum of 3. It has increased from 2.41 (Mar 24) to 2.45, marking an increase of 0.04.
- For Enterprise Value (Cr.), as of Mar 25, the value is 252.41. It has increased from 244.62 (Mar 24) to 252.41, marking an increase of 7.79.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. It has increased from 0.44 (Mar 24) to 0.46, marking an increase of 0.02.
- For EV / EBITDA (X), as of Mar 25, the value is 8.77. This value is within the healthy range. It has increased from 7.92 (Mar 24) to 8.77, marking an increase of 0.85.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has decreased from 0.28 (Mar 24) to 0.27, marking a decrease of 0.01.
- For Retention Ratios (%), as of Mar 25, the value is 90.89. This value exceeds the healthy maximum of 70. It has increased from 87.37 (Mar 24) to 90.89, marking an increase of 3.52.
- For Price / BV (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has decreased from 1.21 (Mar 24) to 1.07, marking a decrease of 0.14.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has decreased from 0.28 (Mar 24) to 0.27, marking a decrease of 0.01.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.07.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in IVP Ltd:
- Net Profit Margin: 2.09%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.32% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.11% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.45
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.91
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 16.1 (Industry average Stock P/E: 389.55)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.74
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.09%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Shashikant N Redij Marg, Ghorupdeo, Mumbai Maharashtra 400033 | ivpsecretarial@ivpindia.com http://www.ivpindia.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. T K Gowrishankar | Chairman & Non-Exe.Director |
| Mr. Mandar P Joshi | WholeTime Director & CEO |
| Mr. Rajkumar Lekhwani | Non Exe.Non Ind.Director |
| Mr. Anwar Chauhan | Non Exe.Non Ind.Director |
| Mrs. Mala Todarwal | Independent Director |
| Mr. Ranjeev Lodha | Independent Director |
| Mr. Pratik Kadakia | Independent Director |
FAQ
What is the intrinsic value of IVP Ltd?
IVP Ltd's intrinsic value (as of 14 November 2025) is 151.99 which is 10.59% lower the current market price of 170.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 176 Cr. market cap, FY2025-2026 high/low of 267/141, reserves of ₹134 Cr, and liabilities of 331 Cr.
What is the Market Cap of IVP Ltd?
The Market Cap of IVP Ltd is 176 Cr..
What is the current Stock Price of IVP Ltd as on 14 November 2025?
The current stock price of IVP Ltd as on 14 November 2025 is 170.
What is the High / Low of IVP Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of IVP Ltd stocks is 267/141.
What is the Stock P/E of IVP Ltd?
The Stock P/E of IVP Ltd is 16.1.
What is the Book Value of IVP Ltd?
The Book Value of IVP Ltd is 139.
What is the Dividend Yield of IVP Ltd?
The Dividend Yield of IVP Ltd is 0.59 %.
What is the ROCE of IVP Ltd?
The ROCE of IVP Ltd is 9.99 %.
What is the ROE of IVP Ltd?
The ROE of IVP Ltd is 8.44 %.
What is the Face Value of IVP Ltd?
The Face Value of IVP Ltd is 10.0.